Anti-inflammatory

• Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases (28 Aug 2024)
  
• Evaluation of cannabinoid receptors type 1–2 in periodontitis patients (27 Aug 2024)
  
• Epigenetic Regulation of Cannabinoid-Mediated Attenuation of Inflammation and Its Impact on the Use of Cannabinoids to Treat Autoimmune Diseases (20 Aug 2024)
  
• Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System (19 Aug 2024)
  
• Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use (24 May 2024)
  
• Inflammation and cancer: friend or foe? (24 May 2024)
  
• Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance (27 Feb 2023)
  
• Quality of Life and a Surveillant Endocannabinoid System (05 Sep 2022)
  
• Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses (01 Sep 2022)
  
• Single Compound vs. Whole Plant CBD (20 Jul 2022)